Toll-like receptor 4 contributes to small intestine allograft rejection

Transplantation

Volumn 90, Issue 12, 2010, Pages 1272-1277

  Krams, Sheri M ^a   Wang, Mouer ^a   Castillo, Ricardo O ^a   Ito, Takashi ^a   Phillips, Lori ^a   Higgins, John ^a   Kambham, Neeraja ^a   Esquivel, Carlos O ^a   Martinez, Olivia M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Small intestine transplantation; TLR4; Toll like receptors

Indexed keywords

TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL MODEL; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOLOGY; IMMUNE RESPONSE; INFLAMMATORY INFILTRATE; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SMALL INTESTINE ALLOGRAFT REJECTION; SMALL INTESTINE TRANSPLANTATION; SURVIVAL TIME; WILD TYPE;

ANIMALS; CYTOKINES; GRAFT REJECTION; GRAFT SURVIVAL; INTESTINAL MUCOSA; INTESTINE, SMALL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; TOLL-LIKE RECEPTOR 4; TRANSPLANTATION, HOMOLOGOUS;

EID: 78650852011     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181fdda0d     Document Type: Article

References (26)

1. Fryer JP. The current status of intestinal transplantation. Curr Opin Organ Transplant 2008; 13: 266.
2. Fishbein TM. Intestinal transplantation. N Engl J Med 2009; 361: 998.
3. Grant D, Abu-Elmagd K, Reyes J, et al. 2003 report of the intestine transplant registry: A new era has dawned. Ann Surg 2005; 241: 607.
4. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140: 805.
5. Erridge C. Endogenous ligands of TLR2 and TLR4: Agonists or assistants? J Leukoc Biol 2010; 87: 989.
6. Kaisho T, Akira S. Regulation of dendritic cell function through tolllike receptors. Curr Mol Med 2003; 3: 759.
7. Weighardt H, Jusek G, Mages J, et al. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells. Eur J Immunol 2004; 34: 558.
8. Goldstein DR, Tesar BM, Akira S, et al. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 2003; 111: 1571.
9. McKay D, Shigeoka A, Rubinstein M, et al. Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection. Eur J Immunol 2006 36 1994.
10. Methe H, Zimmer E, Grimm C, et al. Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation 2004; 78: 1324.
11. Gao Q, Ma LL, Gao X, et al. TLR4 mediates early graft failure after intraportal islet transplantation. Am J Transplant 2010; 10: 1588.
12. Goldberg A, Parolini M, Chin BY, et al. Toll-like receptor 4 suppression leads to islet allograft survival. Faseb J 2007; 21: 2840.
13. Zhai Y, Meng L, Gao F, et al. CD4- T regulatory cell induction and function in transplant recipients after CD154 blockade is TLR4 independent. J Immunol 2006; 176: 5988.
14. Cicalese L, Sileri P, Green M, et al. Bacterial translocation in clinical intestinal transplantation. Transplantation 2001; 71: 1414.
15. Zou Y, Hernandez F, Burgos E, et al. Bacterial translocation in acute rejection after small bowel transplantation in rats. Pediatr Surg Int 2005; 21: 208.
16. Cucchetti A, Siniscalchi A, Bagni A, et al. Bacterial translocation in adult small bowel transplantation. Transplant Proc 2009; 41: 1325.
17. Wang J, Guo Z, Dong Y, et al. Role of 4-1BB in allograft rejection mediated by CD8- T cells. Am J Transplant 2003; 3: 543.
18. Harada E, Ito H, Murakami M, et al. Small bowel transplantation tolerance achieved by costimulatory blockade leading to mixed chimerism. Front Biosci 2007; 12: 3017.
19. Guo Z, Wang J, Dong Y, et al. Long-term survival of intestinal allografts induced by costimulation blockade, busulfan and donor bone marrow infusion. Am J Transplant 2003; 3: 1091.
20. Krams SM, Hayashi M, Fox CK, et al. CD8- cells are not necessary for allograft rejection or the induction of apoptosis in an experimental model of small intestinal transplantation. J Immunol 1998; 160: 3673.
21. Guo Z, Wang J, Meng L, et al. Cutting edge: Membrane lymphotoxin regulates CD8(-s) T cell-mediated intestinal allograft rejection. J Immunol 2001; 167: 4796.
22. Langrehr JM, Gube K, Hammer MH, et al. Short-term anti-CD4 plus anti-TNF-alpha receptor treatment in allogeneic small bowel transplantation results in long-term survival. Transplantation 2007; 84: 639.
23. Zhang Z, Kaptanoglu L, Haddad W, et al. Donor T cell activation initiates small bowel allograft rejection through an IFN-gamma-inducible protein-10-dependent mechanism. J Immunol 2002; 168: 3205.
24. Hayashi M, Martinez OM, Krams SM, et al. Characterization of allograft rejection in an experimental model of small intestinal transplantation. J Gastrointest Surg 1998; 2: 325.
25. Wang J, Dong Y, Sun JZ, et al. Donor lymphoid organs are a major site of alloreactive T-cell priming following intestinal transplantation.AmJ Transplant 2006; 6: 2563.
26. Zhuo M, Fujiki M, Wang M, et al. Identification of the rat NKG2D ligands, RAE1L and RRLT, and their role in allograft rejection. Eur J Immunol 2010; 40: 1748.